蓝帆医疗12月19日获融资买入884.37万元,融资余额3.05亿元

Group 1 - The core viewpoint of the news is that 蓝帆医疗 (Blue Sail Medical) has experienced fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks in the medical device sector [1][2]. Group 2 - On December 19, 蓝帆医疗's stock rose by 2.90%, with a trading volume of 80.37 million yuan. The financing buy-in amount for the day was 8.84 million yuan, while the financing repayment was 7.47 million yuan, resulting in a net financing buy of 1.37 million yuan. The total financing and securities balance reached 305 million yuan [1]. - The financing balance of 蓝帆医疗 is 305 million yuan, accounting for 5.33% of its circulating market value, which is below the 20th percentile level over the past year, indicating a low position [1]. - In terms of securities lending, 蓝帆医疗 repaid 9,500 shares and sold 300 shares on December 19, with a selling amount of 1,704 yuan. The remaining securities lending volume is 92,100 shares, with a balance of 523,100 yuan, which exceeds the 60th percentile level over the past year, indicating a relatively high position [1]. Group 3 - As of November 20, 蓝帆医疗 had 74,200 shareholders, a decrease of 0.12% from the previous period, while the average circulating shares per person increased by 0.12% to 13,464 shares [2]. - For the period from January to September 2025, 蓝帆医疗 reported a revenue of 4.182 billion yuan, a year-on-year decrease of 10.15%, and a net profit attributable to the parent company of -286 million yuan, a year-on-year decrease of 30.09% [2]. - Since its A-share listing, 蓝帆医疗 has distributed a total of 1.348 billion yuan in dividends, with 403 million yuan distributed over the past three years [2]. - As of September 30, 2025, the fifth largest circulating shareholder of 蓝帆医疗 is Hong Kong Central Clearing Limited, holding 8.2141 million shares, a decrease of 8.6208 million shares from the previous period. The medical device ETF (159883) is the tenth largest circulating shareholder, holding 4.9679 million shares as a new shareholder [2].

BLUE SAIL MEDICAL-蓝帆医疗12月19日获融资买入884.37万元,融资余额3.05亿元 - Reportify